SAINT-GOBAIN ENTERS INTO EXCLUSIVE negotiations TO divest pam building, its sanitary and rainwater drainage business
Saint-Gobain has entered into exclusive negotiations for the sale of PAM Building, Saint-Gobain PAM's subsidiary dedicated to the manufacturing of sanitary and rainwater drainage solutions for buildings, to Aldebaran (a French institutional investment fund) with a minority stake from Bpifrance (the French Public Investment Bank).
PAM Building has two production plants, in Bayard (Haute-Marne, France) and in Telford (United Kingdom), employs 400 people and generated revenues of around €110 million in 2023.
This sale would allow Saint-Gobain PAM to focus on its historical core business, the production and delivery of complete water transport and supply networks.
This project has been presented to relevant social partners as part of the information and consultation process prior to the sale.
Closing of the transaction is expected by end-2024.
This divestment project is part of Saint-Gobain's continued business profile optimization strategy, in line with its "Grow & Impact" plan.
About Saint-Gobain
Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".
€47.9 billion in sales in 2023
160,000 employees, locations in 76 countries
Committed to achieving net zero carbon emissions by 2050
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.